Filing Flows › Sonoma Pharmaceuticals (SNOA) › Recalls, complaints & regulation

Sonoma Pharmaceuticals (SNOA): clinical trials

Sonoma Pharmaceuticals (SNOA) beyond its filings: 3 active clinical trials.

Sonoma Pharmaceuticals' latest quarter

Sonoma Pharmaceuticals, Q1 FY27: revenue $6.4M (+60% year over year), operating margin -0.6%, net loss $330K, operating cash flow −$649K. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Sonoma Pharmaceuticals have?

3 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.